Trial intelligence / Profile preview

Continuation of metformin during non-cardiac surgery in adults with type 2 diabetes

NL-OMON24837Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Postoperative glucose at 2 hours after surgery. Started Jul 2015; status: active, not recruiting.

02

Drugs

metformin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NL-OMON24837.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON24837.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call